France-based animal health company Ceva has signed an agreement with South China Agricultural University. Ceva CEO Dr. Marc Prikazsky and Professor Ren Tao of the university signed the agreement in Libourne, France.The agreement allows the university veterinary faculty to test Ceva's Vectormune AI vaccine against other strains of avian influenza. The vaccine is approved for the H5N1 strain of the disease.China consumes more poultry than the United States, and is estimated to be the largest poultry producer by 2020. In 2011, Ceva joined a partnership with a subsidiary of China Agricultural Group. The group currently produces vaccines in Beijing.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment